Biointron (@biointron) 's Twitter Profile
Biointron

@biointron

Only 2 weeks to obtain recombinant antibodies

ID: 1380039555831656450

linkhttps://www.biointron.com calendar_today08-04-2021 06:07:36

18 Tweet

8 Followers

38 Following

Cell Therapy News (@celltherapynews) 's Twitter Profile Photo

Study from Weill Cornell Medicine: šŸ“š The authors suggest that a single treatment with AAVrh.10mAnti‐Eos has the potential to provide persistent therapeutic benefit to patients with #EosinophilicEsophagitis. bit.ly/3sqot3u

Study from <a href="/WeillCornell/">Weill Cornell Medicine</a>: šŸ“š 

The authors suggest that a single treatment with AAVrh.10mAnti‐Eos has the potential to provide persistent therapeutic benefit to patients with #EosinophilicEsophagitis.

bit.ly/3sqot3u
Biointron (@biointron) 's Twitter Profile Photo

BioIntron can provide a quick and professional hybridoma sequencing to get monoclonal antibody sequence for our customers. BioIntron’s HTP rAb expression platform can also help our client to expression the candidate antibody in only 2 weeks after obtaining the sequence.

BioIntron can provide a quick and professional hybridoma sequencing to get monoclonal antibody sequence for our customers. BioIntron’s HTP rAb expression platform can also help our client to expression the candidate antibody in only 2 weeks after obtaining the sequence.
RNA_Biotech (@rna_biotech) 's Twitter Profile Photo

$afmd has entered into a patent and technology license agreement The University of Texas System for the licensing, through The University of Texas M. D. Anderson Cancer Center for NK+AFM13

$afmd  has entered into a patent and technology license agreement  The University of Texas System for the licensing, through The University of Texas M. D. Anderson Cancer Center  for NK+AFM13
Biointron (@biointron) 's Twitter Profile Photo

Biointron Biological Inc. is a leading custom service provider and biological reagents manufacturer specializing in the antibody discovery field.

Biointron Biological Inc. is a leading custom service provider and biological reagents manufacturer specializing in the antibody discovery field.